Federal Judge Halts HHS Vaccine Overhaul, Citing Illegal Appointments

BOSTON, MA – March 16, 2026 – A federal judge today delivered a sweeping rebuke to the health policies of Secretary Kennedy's administration, issuing a preliminary injunction that halts a controversial new pediatric vaccine schedule and freezes the government's primary vaccine advisory body. The ruling represents a major victory for a coalition of America's leading medical and public health organizations, which sued the Department of Health and Human Services (HHS) over what they allege is a politically motivated effort to dismantle decades of science-based immunization policy.

In a decisive move, U.S. District Judge Brian Murphy of the District of Massachusetts stayed 13 recent appointments made by Secretary Kennedy to the CDC's Advisory Committee on Immunization Practices (ACIP), finding they were likely made in violation of federal law. The court also invalidated all votes taken by the committee since those appointments, effectively wiping its recent slate clean.

A Sweeping Injunction Reverses Key Health Directives

The court's order goes far beyond the committee appointments, striking at the heart of the administration's recent changes to national vaccine policy. The preliminary injunction explicitly stays the "heavily revised" pediatric immunization schedule that HHS issued on January 5, 2026. This schedule had caused widespread alarm among pediatricians and public health experts who argued it was not supported by scientific evidence and would leave children vulnerable to preventable diseases.

Furthermore, the injunction reverses other significant actions taken by the administration over the past year. It overturns a May 2025 Secretarial Directive on COVID-19 vaccine recommendations and reverses the downgraded Hepatitis B vaccine recommendations that were approved by the now-stayed ACIP during a December 2025 meeting.

This ruling effectively resets national vaccine guidance to what it was before January 5, 2026, a move celebrated by the plaintiffs—a group that includes the American Academy of Pediatrics (AAP), the American Public Health Association (APHA), and the Infectious Diseases Society of America (IDSA), among others. The court had previously denied the government's motion to dismiss the case, signaling that it viewed the lawsuit, AAP et. al. v Kennedy et. al., as having significant legal merit.

The Law at the Heart of the Ruling: The Federal Advisory Committee Act

Judge Murphy's decision hinges on the administration's likely violation of the Federal Advisory Committee Act (FACA), a 1972 law designed to ensure that government advisory panels are transparent, objective, and free from undue influence. FACA mandates that such committees have a "fairly balanced" membership in terms of the points of view represented and the functions to be performed. It also requires open meetings, public records, and a clear charter outlining the committee's mission.

The plaintiffs argued that Secretary Kennedy's 13 appointments to ACIP—a historically respected body of independent scientific experts—violated FACA by stacking the committee with unqualified individuals who did not represent a balanced range of scientific expertise. The court's finding that a FACA violation was likely was the legal linchpin for issuing the injunction.

By freezing the committee and its work, the court affirmed the principle that the process by which scientific advice is generated is as important as the advice itself. Violations of FACA have been used in the past to challenge government bodies operating in secret or with biased membership, with courts often ordering a halt to their activities until they are brought into compliance. The ruling against the Kennedy-appointed ACIP suggests the court found the procedural flaws so significant that the committee's very legitimacy was in question.

Medical Community Declares Victory for Science and Public Trust

The reaction from the medical and public health community was swift and overwhelmingly positive. Leaders of the plaintiff organizations framed the injunction as a crucial defense of scientific integrity against political interference.

"Today's ruling is an historic and welcomed outcome for children, families, pediatricians and communities across the United States," said Andrew P. Racine, MD, PhD, FAAP, President of the American Academy of Pediatrics. He added that the decision marks "an important step toward restoring scientific decision-making."

The plaintiffs' attorney, Richard Hughes IV of Epstein Becker Green, called the ruling a "momentous step toward restoring science-based vaccine policymaking." He stated, "The judge recognized that the actions of Secretary Kennedy and the Advisory Committee on Immunization Practices are not grounded in science and that they are destructive."

Others emphasized the ruling's potential to repair public trust, which they argued had been damaged by the administration's actions. "Trust occurs when we engage the public in a transparent process, not one where decisions are made behind closed doors by unqualified individuals and presented in a disingenuous way," commented Georges C. Benjamin, MD, CEO of the American Public Health Association.

This sentiment was echoed by leaders from organizations focused on infectious diseases, internal medicine, and maternal-fetal medicine. "Today's ruling is a win for public health and reaffirms that national vaccine policy should be guided by rigorous, evidence-based science, not politics," said Jason M. Goldman, MD, MACP, president of the American College of Physicians.

Political Tremors and an Uncertain Future

The injunction represents a significant political and legal setback for Secretary Kennedy and the current administration's health agenda. By finding a likelihood of illegal conduct, the court has cast a shadow over the administration's management of a critical public health function. As of this evening, the Department of Health and Human Services has not issued an official response to the ruling.

The administration is now faced with a choice: it can attempt to appeal the preliminary injunction, a move that would prolong the legal battle, or it can attempt to reform the ACIP appointment process to comply with FACA. However, the court's earlier refusal to dismiss the case suggests the plaintiffs have a strong underlying argument that will need to be addressed.

For the doctors, nurses, and public health officials on the front lines, the ruling provides immediate clarity and a return to established, evidence-based vaccine schedules. However, leaders of the coalition that brought the suit caution that the fight to protect scientific integrity is far from over.

Carlene Pavlos, Executive Director of the Massachusetts Public Health Alliance, expressed gratitude for the judge's decision but warned of the challenges ahead. "This is not the end. The continuing assaults by the federal administration on vaccine policy and infrastructure have not abated since we and our sister plaintiffs originally filed this complaint and there is no reason to believe they will stop as we move forward," she stated. "But we are all in this because we know that people's health and lives are at risk and we are committed to promoting public health and we will continue to fight over the long road ahead."